Eli Lilly and Company (LLY) vs Oracle Corporation (ORCL)
See how Eli Lilly and Company and Oracle Corporation differ across market data and performance, so you can decide which asset best fits your strategy.
$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page$149.12
NYSE
Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.
View Full PageKey Metrics Comparison
Eli Lilly and CompanyLLY
Market Cap$1.032T
Price$1,156.73
24h Change-1.52%
24h Volume$3.03M
Employees50,000
Shares Outstanding944,818,881
Oracle CorporationORCL
Market Cap$429.536B
Price$149.12
24h Change-1.15%
24h Volume$15.66M
Employees162,000
Shares Outstanding2,876,046,000
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
LLY
70.6%ORCL
29.4%Volume Share
Share of combined 24h volume
LLY
16.2%ORCL
83.8%24h Performance
Price change over last 24 hours
LLY
-1.52%ORCL
-1.15%Price Comparison
Eli Lilly and Company
Oracle Corporation